Evidence-Based Medicine

Catheter-associated Urinary Tract Infection (CAUTI)

Catheter-associated Urinary Tract Infection (CAUTI)

Background

  • CAUTI refers to a urinary tract infection (UTI) while a urinary or suprapubic catheter is in place, shortly after its removal, or in the setting of intermittent catheterization.
  • CAUTI is a common cause of healthcare-associated infection and a leading cause of nosocomial bacteremia. As many as 20% of hospital-acquired bacteremias are of urinary source.
  • As many as 70% of cases may be preventable by limiting unnecessary catheterization and shortening catheterization duration.
  • The duration of catheterization is the single most important, and potentially modifiable, risk factor for infection.
  • Catheters are associated with increased hospital length of stay and morbidity. There are an estimated 13,000 deaths attributable to CAUTI annually in the United States.

Evaluation

  • Symptoms are not always present with catheter-associate bacteriuria.
    • Fever may be the sole presenting symptom.
    • Other systemic symptoms may include malaise, altered mental status, or systemic inflammatory response syndrome.
    • Genitourinary symptoms are often absent, but when present may include suprapubic or flank pain or tenderness.
  • Diagnosis of a symptomatic CAUTI is based on both:
    • the presence of signs or symptoms compatible with a urinary traction infection (not attributable to other causes) such as:
      • fever, rigors, lethargy, flank pain, pelvic discomfort, costovertebral angle tenderness, or hematuria
      • classic UTI symptoms such as dysuria, urgency, frequency, suprapubic tenderness, flank tenderness, nausea, or fever in patients whose catheter has been recently removed
      • other systemic symptoms including altered mental status or systemic inflammatory response syndrome
      • increased spasticity or autonomic dysreflexia in patients with a spinal cord injury or other disorders associated with neurogenic bladder
    • the presence of ≥ 105 colony-forming units (CFU)/mL of ≤ 2 bacterial species
  • When considering treatment for CAUTI, it is important to distinguish symptomatic CAUTI from catheter-associated asymptomatic bacteriuria (CA-ASB).

Management

  • Antibiotic therapy is not recommended for most patients with CA-ASB or asymptomatic funguria.
  • Treatment for asymptomatic bacteriuria is indicated in pregnant women and patients undergoing urological procedures with potential for mucosal bleeding (Strong recommendation). (See Asymptomatic Bacteriuria for additional information)
  • Antimicrobial therapy is recommended for patients with a symptomatic CAUTI (Strong recommendation).
    • Empiric therapy should be selected based on local uropathogen susceptibility patterns.
    • Treatment of symptomatic CAUTI similar to that of complicated UTI (Strong recommendation). (See Complicated Urinary Tract Infection (UTI) for additional information)
    • The catheter should be removed or replaced before starting antimicrobial therapy when feasible (Strong recommendation).
    • Obtain a urine culture before antimicrobial therapy to guide appropriate coverage based on isolated organisms (Strong recommendation).
  • Duration of treatment:
    • 7 days for patients with quick resolution of symptoms (Strong recommendation).
    • 10-14 days for patients with delayed response, regardless of whether patient remains catheterized (Strong recommendation).
    • Consider 5-day course of levofloxacin in patients who are not severely ill (Weak recommendation).
    • Consider 3-day treatment course in women ≤ 65 years old without upper urinary tract symptoms after removal of indwelling catheter (Weak recommendation).
  • If patient does not respond clinically with defervescence within 72 hours, extended treatment and urologic examination may be required.
  • Key preventive measures include:
    • adherence to the appropriate indications for catheter insertion
    • aseptic insertion technique by trained individuals
    • maintenance of closed and unobstructed drainage system
    • removal of catheter as soon as feasible
  • Systemic antimicrobial prophylaxis is not routinely recommended while a catheter is in place or at the time of its removal (Strong recommendation).

Published: 25-06-2023 Updeted: 25-06-2023

References

  1. Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am. 2012 Mar;26(1):13-27
  2. Tambyah PA, Oon J. Catheter-associated urinary tract infection. Curr Opin Infect Dis. 2012 Aug;25(4):365-70
  3. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Peques DA; Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (CDC HICPAC). Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010 Apr;31(4):319-26, updated 2017 Feb, also available at
  4. Hooton TM, Bradley SF, Cardenas DD, et al; Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1;50(5):625-63, commentary can be found in Clin Infect Dis 2010 Aug 15;51(4):479
  5. Bonkat G, Bartoletti R, Bruyère F, et al. European Association of Urology Guidelines on Urological Infections. EAU 2023 (PDF)
  6. Lo E, Nicolle LE, Coffin SE, et al; Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA/IDSA). Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S32-47

Related Topics